Kauniolide is primarily studied for its potential therapeutic applications, particularly in the field of cancer research. It has shown promising anticancer properties by inducing apoptosis (programmed cell death) in various cancer cell lines. This makes it a candidate for developing novel chemotherapeutic agents. Additionally, kauniolide exhibits anti-inflammatory effects, which could be beneficial in treating inflammatory diseases or conditions. Its mechanism of action involves modulating specific cellular pathways, making it a subject of interest for further pharmacological and clinical studies. Researchers are also exploring its potential in combination therapies to enhance its efficacy and reduce side effects.